◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › C › COR

Cencora Inc. (COR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Distributors · DATA UPDATED 2026-09-06

Cencora Inc. (COR) operates in the Health Care Distributors industry and is headquartered in Conshohocken, United States with about 47,000 employees. Its market capitalization is roughly $59 billion. In the fiscal year ended 2025-09-30, COR reported $321.3B in revenue and $1.6B in net income.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.

Interactive charts & full statements → Open the COR valuation workbench →

COR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Revenue	$332.8B	$321.3B	$294.0B	$262.2B	$238.6B	$214.0B	$189.9B	$179.6B	$167.9B	$153.1B	$146.8B	$136.0B	$119.6B	$88.0B	$79.5B	$80.2B	$78.0B	$71.8B	$70.2B	$66.1B	$61.2B
Gross Profit	$12.3B	$10.1B	$8.7B	$7.8B	$7.6B	$6.3B	$4.8B	$4.5B	$4.1B	$4.1B	$3.8B	$3.2B	$2.8B	$2.3B	$2.5B	$2.4B	$2.2B	$2.0B	$1.9B	$2.2B	$2.1B
Gross Margin %	3.7%	3.2%	3.0%	3.0%	3.2%	2.9%	2.5%	2.5%	2.5%	2.7%	2.6%	2.4%	2.3%	2.6%	3.2%	3.0%	2.9%	2.8%	2.8%	3.3%	3.4%
Operating Income (EBIT)	$4.3B	$3.6B	$3.0B	$2.4B	$2.8B	$2.7B	$2.0B	$1.9B	$1.7B	$2.0B	$1.7B	$1.3B	$1.2B	$989M	$1.3B	$1.2B	$1.1B	$899M	$824M	$787M	$728M
Operating Margin %	1.3%	1.1%	1.0%	0.9%	1.1%	1.2%	1.1%	1.0%	1.0%	1.3%	1.1%	1.0%	1.0%	1.1%	1.6%	1.5%	1.4%	1.2%	1.2%	1.2%	1.2%
Net Income	$2.6B	$1.6B	$1.5B	$1.7B	$1.7B	$1.5B	($3.4B)	$855M	$1.7B	$414M	$1.4B	($135M)	$276M	$434M	$719M	$707M	$637M	$503M	$251M	$469M	$468M
Net Margin %	0.8%	0.5%	0.5%	0.7%	0.7%	0.7%	-1.8%	0.5%	1.0%	0.3%	1.0%	-0.1%	0.2%	0.5%	0.9%	0.9%	0.8%	0.7%	0.4%	0.7%	0.8%
EBITDA	$5.1B	$3.7B	$3.4B	$3.4B	$3.1B	$2.9B	($4.7B)	$1.7B	$1.9B	$1.5B	$1.9B	$631M	$939M	$1.1B	$1.4B	$1.3B	$1.2B	$978M	$929M	$960M	$846M
Earnings Per Share (EPS)	$13.45	$7.96	$7.53	$8.53	$8.04	$7.39	$-16.60	$4.04	$7.53	$1.87	$6.32	$-0.62	$1.17	$1.84	$2.80	$2.54	$2.22	$1.66	$0.77	$1.25	$1.13
Shares Outstanding (M)	194M	195M	200M	205M	211M	208M	205M	212M	220M	222M	226M	218M	235M	235M	257M	278M	287M	303M	325M	376M	415M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$84.8B	$78.4B	$85.9B	$83.7B	$80.7B	$75.5B	$81.5B	$79.0B
Gross Profit	$3.6B	$3.3B	$2.8B	$2.6B	$2.7B	$2.6B	$2.3B	$2.2B
Gross Margin %	4.3%	4.2%	3.3%	3.1%	3.3%	3.5%	2.8%	2.7%
Operating Income (EBIT)	$1.1B	$1.3B	$1.0B	$855M	$986M	$1.0B	$792M	$673M
Operating Margin %	1.3%	1.7%	1.2%	1.0%	1.2%	1.4%	1.0%	0.9%
Net Income	$764M	$1.6B	$560M	($340M)	$687M	$718M	$489M	$3M
Net Margin %	0.9%	2.1%	0.7%	-0.4%	0.9%	0.9%	0.6%	0.0%
EBITDA	$1.4B	$2.5B	$1.0B	$183M	$1.3B	$1.3B	$961M	$458M
Earnings Per Share (EPS)	$3.94	$8.40	$2.87	$-1.75	$3.52	$3.68	$2.50	$0.02
Shares Outstanding (M)	194M	195M	195M	194M	195M	195M	195M	200M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COR Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Cash from Operations (CFO)	$4.8B	$3.9B	$3.5B	$3.9B	$2.7B	$2.7B	$2.2B	$2.3B	$1.4B	$1.5B	$3.2B	$3.9B	$1.5B	$788M	$1.3B	$1.2B	$1.1B	$784M	$737M	$1.2B	$807M
Capital Expenditures (CapEx)	$761M	$668M	$487M	$458M	$496M	$438M	$370M	$310M	$336M	$466M	$465M	$232M	$264M	$202M	$164M	$168M	$185M	$146M	$137M	$118M	$113M
Free Cash Flow (FCF)	$4.1B	$3.2B	$3.0B	$3.5B	$2.2B	$2.2B	$1.8B	$2.0B	$1.1B	$1.0B	$2.7B	$3.7B	$1.2B	$586M	$1.1B	$1.0B	$924M	$638M	$600M	$1.1B	$694M
FCF Margin %	1.2%	1.0%	1.0%	1.3%	0.9%	1.0%	1.0%	1.1%	0.6%	0.7%	1.8%	2.7%	1.0%	0.7%	1.4%	1.2%	1.2%	0.9%	0.9%	1.7%	1.1%
Dividends Paid	$468M	$437M	$416M	$399M	$392M	$367M	$344M	$339M	$333M	$320M	$288M	$254M	$214M	$196M	$133M	$118M	$91M	$63M	$49M	$37M	$21M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$2.7B	$1.3B	($2.3B)	$3.1B	$109M	$3.4B	($2.7B)	$1.0B
Capital Expenditures (CapEx)	$226M	$166M	$119M	$250M	$183M	$129M	$106M	$182M
Free Cash Flow (FCF)	$2.4B	$1.2B	($2.4B)	$2.9B	($74M)	$3.2B	($2.8B)	$818M
FCF Margin %	2.9%	1.5%	-2.8%	3.4%	-0.1%	4.3%	-3.5%	1.0%
Dividends Paid	$117M	$117M	$127M	$108M	$107M	$111M	$111M	$101M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COR Balance Sheet History

Balance sheet	2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Assets	$83.8B	$76.6B	$67.1B	$62.6B	$56.6B	$57.3B	$44.3B	$39.2B	$37.7B	$35.3B	$33.6B	$27.7B	$21.5B	$18.9B	$15.4B	$15.0B	$14.4B	$13.6B	$12.2B	$12.3B	$12.8B
Cash & Cash Equivalents	$2.8B	$4.4B	$3.2B	$2.7B	$3.5B	$2.5B	$4.6B	$3.4B	$2.5B	$2.4B	$2.7B	$2.2B	$1.8B	$1.2B	$1.1B	$1.8B	$1.7B	$1.0B	$878M	$640M	$1.3B
Total Liabilities	$80.6B	$74.8B	$66.3B	$61.9B	$56.5B	$56.8B	$45.1B	$36.5B	$35.0B	$33.3B	$31.5B	$27.3B	$19.6B	$16.6B	$13.0B	$12.1B	$11.5B	$10.9B	$9.5B	$9.2B	$8.6B
Total Debt (Short + Long-Term)	$11.7B	$7.9B	$4.6B	$5.0B	$5.9B	$6.9B	$4.2B	$4.2B	$152M	$12M	$610M	$142M	$0M	$0M	$0M	$392M	$0M	$1M	$2M	$0M	$2M
Total Shareholders' Equity	$3.1B	$1.5B	$646M	$522M	($212M)	$223M	($1.0B)	$2.9B	$2.9B	$2.1B	$2.1B	$616M	$2.0B	$2.3B	$2.5B	$2.9B	$3.0B	$2.7B	$2.7B	$3.1B	$4.1B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive COR viewer.

COR Metric Deep Dives

Other Companies in Health Care Distributors

MCK · McKesson Corporation — $102 billion
CAH · Cardinal Health — $52 billion
HSIC · Henry Schein — $9 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← COPZ All “C” companies CORALFINAC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.